These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 12520750)
1. [Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion]. Zhao Y; Wang SM; Zhang J Ai Zheng; 2002 Dec; 21(12):1365-7. PubMed ID: 12520750 [TBL] [Abstract][Full Text] [Related]
2. Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer. Breathnach OS; Georgiadis MS; Schuler BS; Pizzella P; Llorens V; Kasturi V; Steinberg SM; O'Neil K; Takimoto CH; Johnson BE Clin Cancer Res; 2000 Jul; 6(7):2670-6. PubMed ID: 10914708 [TBL] [Abstract][Full Text] [Related]
3. [Nadaplatin or cisplatin combined with paclitaxol in treatment for non-small cell lung cancer: a randomized controlled study]. Chen LK; Xu GC; Guan ZZ; Hang Y; Yang QY Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):437-40. PubMed ID: 17974278 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin. Rowinsky EK; Jiroutek M; Bonomi P; Johnson D; Baker SD Clin Cancer Res; 1999 Apr; 5(4):767-74. PubMed ID: 10213211 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of treatment efficacy of the second and the third generations of chemoradiotherapy regimens containing platinum on advanced non-small cell lung cancer]. Wang YM; Guo LJ; Li LS; Li P; Zheng J; Li L Ai Zheng; 2005 Dec; 24(12):1514-7. PubMed ID: 16351804 [TBL] [Abstract][Full Text] [Related]
6. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC. Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980 [TBL] [Abstract][Full Text] [Related]
7. [Comparision of high dose impulsion and low dose density chemotherapeutic regimens with paclitaxel plus cisplatin in advanced NSCLC]. Hua XM; Ren XW; Liu FL; Liu Y; Zhang CJ; Li ZJ; Xu L; Liu JY; Liu YG Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):621-5. PubMed ID: 15634526 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma. Nguyen NP; Leonardo JM; Karlsson U; Vos P; Bullock L; Thomas P; Lepera P; Ludin A; Chu C; Salehpour M; Jendrasiak G; Sallah S Anticancer Res; 2002; 22(6B):3429-35. PubMed ID: 12552935 [TBL] [Abstract][Full Text] [Related]
9. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136 [TBL] [Abstract][Full Text] [Related]
10. [Symptomatic treatment versus combination chemotherapy in advanced non-small cell lung cancer]. Xu G; Liu G Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):60-2. PubMed ID: 11776801 [TBL] [Abstract][Full Text] [Related]
11. Phase II study of patients with metastatic nonsmall cell carcinoma of the lung treated with paclitaxel by 3-hour infusion. Tester WJ; Jin PY; Reardon DH; Cohn JB; Cohen MH Cancer; 1997 Feb; 79(4):724-9. PubMed ID: 9024710 [TBL] [Abstract][Full Text] [Related]
12. [Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases]. Zhang X; Sun Y; Feng F Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):220-3. PubMed ID: 11776842 [TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer. Pohl G; Krajnik G; Malayeri R; Müller RM; Klepetko W; Eckersberger F; Schäfer-Prokop C; Pokrajac B; Schmeikal S; Maier A; Ambrosch G; Woltsche M; Minar W; Pirker R Lung Cancer; 2006 Oct; 54(1):63-7. PubMed ID: 16926060 [TBL] [Abstract][Full Text] [Related]
14. [Intrapericardial infusion of etoposide and cisplatin in treating malignant pericardial effusion of non-small cell lung cancer]. Chen LK; Xu GC; Liang Y; Yang QY; Zhang LN Ai Zheng; 2006 Apr; 25(4):505-8. PubMed ID: 16613690 [TBL] [Abstract][Full Text] [Related]
15. Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer. Chen CH; Lin CM; Kao KC; Chang JW; Tsao TC Chang Gung Med J; 2007; 30(3):249-55. PubMed ID: 17760276 [TBL] [Abstract][Full Text] [Related]
16. [Comparison of NP and MVP regimen in treatment of advanced non-small cell lung cancer]. Qiang E; Wang SP; Liu SJ; Yiao J Ai Zheng; 2002 Dec; 21(12):1362-4. PubMed ID: 12520749 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of non-small-cell lung cancer by dual (bronchial and pulmonary) arterial drug infusion]. Shi W; Zhang S; Zhang X Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):146-8. PubMed ID: 7656809 [TBL] [Abstract][Full Text] [Related]
18. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer. Ceresoli GL; Gregorc V; Cordio S; Bencardino KB; Schipani S; Cozzarini C; Bordonaro R; Villa E Lung Cancer; 2004 May; 44(2):231-9. PubMed ID: 15084388 [TBL] [Abstract][Full Text] [Related]
19. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC). Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC). Pereira JR; Martins SJ; Nikaedo SM; Ikari FK BMC Cancer; 2004 Sep; 4():69. PubMed ID: 15456520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]